Abbott RealTime HCV Genotype II RUO assay 的性能。
Performance of the Abbott RealTime HCV Genotype II RUO assay.
机构信息
Infectious Diseases Laboratory, Medical Service, Veterans Affairs Medical Center, Washington, DC, USA.
出版信息
J Clin Microbiol. 2012 Sep;50(9):3099-101. doi: 10.1128/JCM.01249-12. Epub 2012 Jul 3.
Abstract
The Abbott RealTime HCV Genotype II RUO (research use only) assay was evaluated using the automated Abbott RealTime m2000 system. Concordance was 98% (81/83 samples) with samples previously typed by the Versant HCV Genotype 2.0 RUO system with manual extraction. The total assay time was reduced from 10.5 to 6.0 h and hands-on time from 13 to 4 min/patient sample.
摘要
Abbott RealTime HCV Genotype II RUO（仅供研究使用）检测试剂在自动化 Abbott RealTime m2000 系统上进行了评估。与之前使用手动提取的 Versant HCV Genotype 2.0 RUO 系统进行分型的 83 个样本相比，其符合率为 98%（81/83 个样本）。总检测时间从 10.5 小时缩短至 6.0 小时，手动操作时间从 13 分钟/患者样本减少至 4 分钟/患者样本。
相似文献
1
Performance of the Abbott RealTime HCV Genotype II RUO assay. Abbott RealTime HCV Genotype II RUO assay 的性能。
J Clin Microbiol. 2012 Sep;50(9):3099-101. doi: 10.1128/JCM.01249-12. Epub 2012 Jul 3.
2
A multicenter evaluation of the Abbott RealTime HCV Genotype II assay.Abbott RealTime HCV Genotype II assay 的多中心评估。
J Virol Methods. 2010 Aug;167(2):205-7. doi: 10.1016/j.jviromet.2010.03.017. Epub 2010 Mar 31.
3
Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping.Abbott RealTime HCV Genotyping II、Abbott HCV Genotype plus RUO 和 Roche Cobas HCV Genotyping assays 用于丙型肝炎病毒基因分型的诊断性能比较。
J Med Virol. 2024 May;96(5):e29686. doi: 10.1002/jmv.29686.
4
Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping.雅培实时丙型肝炎病毒基因II型检测法与Versant线性探针检测法2.0用于丙型肝炎病毒基因分型的比较。
J Clin Microbiol. 2015 May;53(5):1754-7. doi: 10.1128/JCM.03548-14. Epub 2015 Mar 4.
5
Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assay.雅培仅用于研究的实时丙型肝炎病毒（HCV）检测方法的评估以及与罗氏TaqMan HCV分析物特异性试剂检测方法的比较。
J Clin Microbiol. 2009 Sep;47(9):2872-8. doi: 10.1128/JCM.02329-08. Epub 2009 Jul 22.
6
Performance of the Abbott RealTime and Roche Cobas TaqMan hepatitis C virus (HCV) assays for quantification of HCV genotypes.Abbott RealTime 和 Roche Cobas TaqMan 丙型肝炎病毒（HCV）检测试剂定量检测 HCV 基因型的性能。
J Clin Microbiol. 2012 May;50(5):1769-72. doi: 10.1128/JCM.06723-11. Epub 2012 Feb 29.
7
Performance evaluation of the Aptima HCV Quant Dx assay for hepatitis C virus (HCV) RNA detection and quantification in comparison to the Abbott RealTime HCV assay.Aptima HCV Quant Dx assay 与 Abbott RealTime HCV assay 比较，用于丙型肝炎病毒 (HCV) RNA 检测和定量的性能评估。
J Clin Virol. 2017 Jul;92:1-6. doi: 10.1016/j.jcv.2017.04.013. Epub 2017 Apr 26.
8
Utility of the Abbott RealTime HCV Genotype Plus RUO assay used in combination with the Abbott RealTime HCV Genotype II assay. Abbott RealTime HCV Genotype Plus RUO 检测与 Abbott RealTime HCV Genotype II 检测联合使用的效用。
J Clin Virol. 2018 Feb-Mar;99-100:97-100. doi: 10.1016/j.jcv.2018.01.004. Epub 2018 Jan 12.
9
The need for a sequencing-based assay to supplement the Abbott m2000 RealTime HCV Genotype II assay: a 1 year analysis.需要基于测序的检测方法来补充 Abbott m2000 RealTime HCV Genotype II 检测方法：为期 1 年的分析。
J Clin Virol. 2014 Jul;60(3):301-4. doi: 10.1016/j.jcv.2014.04.005. Epub 2014 Apr 14.
10
Evaluation of the Abbott RealTime HCV genotype II plus RUO (PLUS) assay with reference to core and NS5B sequencing.参照核心区和NS5B测序对雅培实时丙型肝炎病毒基因2型检测试剂（RUO，PLUS）的评估。
J Clin Virol. 2017 May;90:26-31. doi: 10.1016/j.jcv.2017.03.007. Epub 2017 Mar 9.
引用本文的文献
1
Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test.使用新的雅培丙型肝炎病毒基因分型加RUO检测法，通过雅培实时丙型肝炎病毒基因分型II检测法对鉴定为无亚型的丙型肝炎病毒1型样本进行特征分析。
J Clin Microbiol. 2016 Feb;54(2):296-9. doi: 10.1128/JCM.02264-15. Epub 2015 Nov 18.
2
Hepatitis C virus: Virology, diagnosis and treatment.丙型肝炎病毒：病毒学、诊断与治疗
World J Hepatol. 2015 Jun 8;7(10):1377-89. doi: 10.4254/wjh.v7.i10.1377.
3
Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging.丙型肝炎病毒感染诊断及肝纤维化分期工具。
World J Gastroenterol. 2014 Apr 7;20(13):3431-42. doi: 10.3748/wjg.v20.i13.3431.
本文引用的文献
1
Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office.慢性丙型肝炎病毒感染管理和治疗进展：来自退伍军人事务部丙型肝炎资源中心项目和国家丙型肝炎项目办公室的建议。
Am J Gastroenterol. 2012 May;107(5):669-89; quiz 690. doi: 10.1038/ajg.2012.48.
2
Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.博赛泼维与特拉泼维在丙型肝炎病毒感染者治疗中的应用。
Clin Infect Dis. 2012 Jan 1;54(1):96-104. doi: 10.1093/cid/cir774. Epub 2011 Dec 7.
3
Telaprevir for retreatment of HCV infection.特拉匹韦治疗丙型肝炎病毒感染。
N Engl J Med. 2011 Jun 23;364(25):2417-28. doi: 10.1056/NEJMoa1013086.
4
Telaprevir for previously untreated chronic hepatitis C virus infection.替拉瑞韦治疗初治慢性丙型肝炎病毒感染。
N Engl J Med. 2011 Jun 23;364(25):2405-16. doi: 10.1056/NEJMoa1012912.
5
Boceprevir for previously treated chronic HCV genotype 1 infection.博赛泼维用于治疗既往慢性 HCV 基因 1 型感染。
N Engl J Med. 2011 Mar 31;364(13):1207-17. doi: 10.1056/NEJMoa1009482.
6
Boceprevir for untreated chronic HCV genotype 1 infection.博赛泼维用于治疗未经治疗的慢性 HCV 基因 1 型感染。
N Engl J Med. 2011 Mar 31;364(13):1195-206. doi: 10.1056/NEJMoa1010494.
7
A multicenter evaluation of the Abbott RealTime HCV Genotype II assay.Abbott RealTime HCV Genotype II assay 的多中心评估。
J Virol Methods. 2010 Aug;167(2):205-7. doi: 10.1016/j.jviromet.2010.03.017. Epub 2010 Mar 31.
8
Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping.Abbott RealTime HCV Genotype II 用于丙型肝炎病毒基因分型的性能评估。
Clin Chem Lab Med. 2010 Apr;48(4):469-74. doi: 10.1515/CCLM.2010.093.
9
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.1999年至2002年美国丙型肝炎病毒感染的流行情况。
Ann Intern Med. 2006 May 16;144(10):705-14. doi: 10.7326/0003-4819-144-10-200605160-00004.
10
Elevated prevalence of hepatitis C infection in users of United States veterans medical centers.美国退伍军人医疗中心使用者中丙型肝炎感染率升高。
Hepatology. 2005 Jan;41(1):88-96. doi: 10.1002/hep.20502.
Zotero 插件